Swiss industrial group Metall Zug reported a 1.5% rise in first-half revenue to CHF 95.6 million for 2026, though currency effects shaved 4.1 percentage points from growth. Organic revenue increased 5.5%, the company said on Monday.
The group’s reported EBIT loss narrowed to CHF 3.7 million from CHF 12.6 million a year earlier. Net loss for the period decreased to CHF 4.4 million from CHF 10.3 million in the prior-year period.
Within Metall Zug’s largest segment, Medical Devices, revenue rose 1.5% to CHF 78.2 million. Adjusted for currency effects, organic growth reached 6.5%, driven by strong demand for slit lamps. The segment’s EBIT turned positive at CHF 2.7 million, reversing a CHF 2.6 million loss in the same period last year.
The Technologycluster & Infra segment also improved, with EBIT increasing to CHF 2.1 million from CHF 0.8 million a year ago, supported by higher rental income from the SHL-Südtor project.
Strategic investments weighed on results, with the segment reporting an EBIT loss of CHF 8.5 million, an improvement from CHF 10.8 million in the prior year. V-ZUG performed positively, while Komax and SteelcoBelimed weighed on results. The Gehrig Group also remained unprofitable.
Metall Zug did not provide specific financial guidance for the full year, citing limited visibility amid economic, political and currency uncertainties. The group expressed confidence in its long-term growth prospects, citing a "solid foundation" for future expansion.
